CLINICAL RESEARCH
The Prognostic Importance of Nonsignificant Left Main Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention
Gabor Gyenes, MD, PhD*,*,
Fiona M. Shrive, BSc ,
Michelle M. Graham, MD, FRCP(C)*,
William A. Ghali, MD, FRCP(C),
Merrill L. Knudtson, MD, FCRP(C) the APPROACH Investigators
* University of Alberta, Edmonton, Alberta, Canada
University of Calgary, Calgary, Alberta, Canada
Manuscript received December 31, 2005;
revised manuscript received February 16, 2006,
accepted February 21, 2006.
* Reprint requests and correspondence: Dr. Gabor Gyenes, University of Alberta Hospital, 2C2 Walter Mackenzie Health Sciences Centre, 8440-112 Street, Edmonton, AB, Canada T6G 2B7 (Email: ggyenes{at}cha.ab.ca).
OBJECTIVES: The purpose of this research was to study the association between nonsignificant (<50%) left main coronary artery disease (LMCAD) and short- and long-term survival in patients undergoing percutaneous coronary intervention (PCI).
BACKGROUND: The prognostic importance of nonsignificant LMCAD is unknown; however, the co-existence of nonsignificant LMCAD may influence revascularization decisions.
METHODS: We analyzed mortality and repeat catheterization rates of 11,855 patients in a prospective cardiac registry database who underwent single-vessel or multivessel PCI from January 1996 through December 2001. Of this cohort, 11.7% (n = 1,385) had nonsignificant (<50%) LMCAD. Outcomes were compared with those without LMCAD. A secondary analysis was performed on a larger cohort of 34,586 patients undergoing cardiac catheterization, irrespective of mode of revascularization therapy.
RESULTS: Patients with nonsignificant LMCAD had more co-morbidities, and a significantly higher crude mortality rate at 1 year compared with those without LMCAD (4.4% vs. 3.4%; p = 0.05). The 7-year crude mortality hazard ratio (HR) of PCI patients with <50% LMCAD versus those with no LMCAD was 1.18 (95% confidence interval [CI] 0.94 to 1.46). After risk adjustment for differences in baseline clinical profile, however, the HR decreased to 0.98 (95% CI 0.79 to 1.23). Repeat catheterization rates at 1 year did not differ between groups. The secondary analysis in all patients with nonsignificant LMCAD showed an adjusted HR of 1.03 (95% CI 0.94 to 1.14).
CONCLUSIONS: Patients undergoing single-vessel or multivessel PCI who have <50% LMCAD have a nonsignificantly increased 18% relative risk for mortality compared with those without detectable LMCAD that appears to be related to these patients' higher incidence of co-morbidities rather than the left main stenosis itself.
|
Abbreviations and Acronyms
| | APPROACH = Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease | | CABG = coronary artery bypass grafting | | CI = confidence interval | | HR = hazard ratio | | IVUS = intravascular ultrasound | | LMCAD = left main coronary artery disease | | PCI = percutaneous coronary intervention |
|
This article has been cited by other articles:
|
|
|
|
 
S. Darabian, A. Reza Amirzadegan, H. Sadeghian, S. Sadeghian, A. Abbasi, and M. Raeesi
Ostial Lesions of Left Main and Right Coronary Arteries: Demographic and Angiographic Features
Angiology,
January 1, 2009;
59(6):
682 - 687.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. T. Gyenes and W. A. Ghali
Should All Patients With Asymptomatic but Significant (>50%) Left Main Coronary Artery Stenosis Undergo Surgical Revascularization?
Circulation,
July 22, 2008;
118(4):
422 - 425.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol.,
July 17, 2007;
50(3):
270 - 285.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al.
Highlights of the Year in JACC 2006
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
509 - 527.
[Full Text]
[PDF]
|
|
|
|
